tue
JULY 28, 2020 / 4:39 pm 4:39
pm
Wall Street falls as pandemic hurts consumer confidence
and earnings; stimulus
plan underwhelms
DJ: 26,584.77 +114.88 NAS: 10,536.27
+173.09 S&P: 3,239.41
+23.78 7/27
DJ: 26,379.28 -205.49 NAS: 10,402.09 -134.18 S&P: 3,218.44
-20.97 7/28
(Reuters) - Wall Street
closed lower on Tuesday as investors fretted about weakening consumer
confidence, disappointing financial results and as investors worried about
wrangling in the U.S. Congress over a coronavirus aid plan. Weighing heavily on the Dow were industrial
conglomerate 3M Co (MMM.N), down 4.8%, after it reported a second-quarter
plunge in demand across its businesses and McDonald’s Corp (MCD.N),
which fell 2.5%, after a surprisingly big drop in global same-store sales. Data released in the morning showed U.S.
consumer confidence ebbed in July as coronavirus infections flared up across
the country.
As they waited on a stimulus package agreement and for quarterly
reports in one of the busiest weeks in earnings season, investors were also anticipating the U.S.
Federal Reserve’s Wednesday wrap-up of its two day policy meeting. “It’s probably not a bad place to take some
profits and rebuild some liquidity because any of those three events could lead
to volatility,” said Sameer Samana, Senior Global Market Strategist at Wells
Fargo Investment Institute in St. Louis.
Samana said “its
going to be very hard for the Fed to surprise on the positive side.”
Meanwhile, Florida
reported a record one-day rise in coronavirus deaths, and cases in Texas passed the 400,000 mark,
stoking fears the United States was losing control of the outbreak. Mark Luschini, chief investment strategist at
Janney Montgomery Scott in Philadelphia, called the consumer survey
“unsettling” evidence that “individuals are increasingly concerned about the recent surge in
coronavirus impacting their finances and their mobility.”
Feeding the fears, members of congress were sparring over a $1 trillion aid
proposal from Senate Republicans announced on Monday, four days before millions of Americans lose
unemployment benefits. “There has to be tremendous compromise from
both parties to get to some agreement,” Luschini said, noting a congressional
recess scheduled for August adds deadline pressure. “It’s particularly critical at this time since the market is really
feeding off the largess that’s been expended by fiscal and monetary
authorities,” he said. The indexes lost
further ground late in the session after U.S. Senate Majority Leader Mitch
McConnell said no coronavirus bill would be brought to the senate floor without
legal liability protections for corporations, a measure opposed by the
Democratic majority in the House of Representatives [W1N2CF03A]
The
Dow Jones Industrial Average .DJI fell 205.49 points, or 0.77%, to 26,379.28,
the S&P 500 .SPX lost 20.97 points, or 0.65%, to 3,218.44 and
the Nasdaq Composite .IXIC dropped 134.18 points, or 1.27%, to
10,402.09. Materials .SPLRCM, energy .SPNY and consumer
discretionary .SPLRCD were the biggest percentage decliners of the S&P’s 11
major sectors. Defensive real estate .SPLRCR, utilities .SPLRCU and consumer
staples .SPLRCS sectors were the only gainers.
Another focus this week is results from
Wall Street’s trillion-dollar market value companies - Apple Inc (AAPL.O),
Amazon.com Inc (AMZN.O) and Alphabet Inc (GOOGL.O) -
as well as Facebook Inc (FB.O).
Of the S&P 500 companies that have reported earnings so far this quarter,
about 80% surpassed significantly lowered profit forecasts, according to
Refinitiv IBES data. Pfizer Inc (PFE.N)
shares rose 3.9% after it raised its full-year forecast a day after it
announced a pivotal global study to evaluate a COVID-19 vaccine candidate.
Declining issues outnumbered advancing ones on the NYSE by a
1.25-to-1 ratio; on Nasdaq, a 1.97-to-1 ratio favored decliners. The S&P 500 posted 25 new 52-week highs and
no new lows; the Nasdaq Composite recorded 56 new highs and 22 new lows.
On U.S. exchanges 9.28 billion shares changed hands compared with the 10.56
billion average for the last 20 sessions.
No comments:
Post a Comment